Deanna L. Kirkpatrick

Davis Polk advised the underwriters in connection with the SEC-registered offering of $1.5 billion aggregate principal amount of 2.200% bonds due July 26, 2022, issued by the Province…

Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public offering of common stock of Kala Pharmaceuticals, Inc. The…

Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on…

Davis Polk advised the underwriters in connection with the offering of $500 million aggregate principal amount of 1.625% U.S. dollar bonds due 2020 issued by Export Development Canada. The…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 2.250% bonds due May 18, 2022, issued by the Province of Ontario. The Davis…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 2.000% U.S. dollar bonds due 2022 issued by Export Development Canada…

Davis Polk advised the joint lead dealer managers in connection with the registered offers by Abbott Laboratories to exchange certain outstanding debt securities of St. Jude Medical,…

Davis Polk advised the sole sales agent in connection with an SEC-registered at-the-market offering by Tellurian Inc. of its shares of common stock having an aggregate offering price of up…

Davis Polk advised the underwriters in connection with the offering of $2.5 billion aggregate principal amount of 2.400% bonds due February 8, 2022, issued by the Province of Ontario. The…

Davis Polk advised the underwriters in connection with the offering by the Province of Ontario of C$800 million aggregate principal amount of its 1.95% bonds due January 27, 2023. The bonds…